GLP-1 receptor agonists and delayed gastric emptying: Another opportunity to use gastric ultrasound prior to the induction of general anesthesia Myron Yaster MD and Suryakumar Narayanasamy, MBBS, MD In yesterdays PAAD here, we reviewed the physiology of Glucagon-like peptide-1 (GLP-1) receptor agonist drugs which have transformed the management of type 2 diabetes and obesity
Li CC, Malik SM, Blaeser BF, Dehni WJ, Kabani SP, Boyle N, et al
Someone who is physically active, tolerates tirzepatide well, and wants to maximize fat loss composition would lean toward levocarnitine
Retatrutide produces substantially more weight loss
The aim of the present narrative review was to describe the gastrointestinal adverse effects of the antidiabetic drugs, their pathophysiologic mechanisms, and the corresponding therapeutic measures